320 related articles for article (PubMed ID: 12555559)
1. [Stable expression and immunogenicity in a attenuated Salmonella typhi strain of coli surface antigen-6 of enterotoxigenic Escherichia coli].
Teng J; Rui X; Zhang Y; Zhang Z; Su G
Wei Sheng Wu Xue Bao; 1999 Dec; 39(6):533-8. PubMed ID: 12555559
[TBL] [Abstract][Full Text] [Related]
2. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
3. Improvement of the live vaccine strain Salmonella enterica serovar Typhi Ty21a for antigen delivery via the hemolysin secretion system of Escherichia coli.
Hotz C; Fensterle J; Goebel W; Meyer SR; Kirchgraber G; Heisig M; Fürer A; Dietrich G; Rapp UR; Gentschev I
Int J Med Microbiol; 2009 Feb; 299(2):109-19. PubMed ID: 18706861
[TBL] [Abstract][Full Text] [Related]
4. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
[TBL] [Abstract][Full Text] [Related]
5. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
[TBL] [Abstract][Full Text] [Related]
6. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
[TBL] [Abstract][Full Text] [Related]
7. Cloning, expression and characterization of heat shock protein 60 (groEL) of Salmonella enterica serovar Typhi and its role in protective immunity against lethal Salmonella infection in mice.
Paliwal PK; Bansal A; Sagi SS; Mustoori S; Govindaswamy I
Clin Immunol; 2008 Jan; 126(1):89-96. PubMed ID: 18024219
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
[TBL] [Abstract][Full Text] [Related]
9. Construction of a Salmonella typhimurium vaccine strain expressing Vibrio cholera CT-B and LPS-O antigen.
Chen D; Ma Q
Chin J Biotechnol; 1997; 13(1):43-50. PubMed ID: 9376506
[TBL] [Abstract][Full Text] [Related]
10. [Cloning of a cluster of genes encoding coli-surface antigen 6(CS6) of human enterotoxigenic E. coli].
Yang X; Zhang Z; Liu C; Zhang B; Chen T; Huang C
Wei Sheng Wu Xue Bao; 1995 Oct; 35(5):390-3. PubMed ID: 8701585
[TBL] [Abstract][Full Text] [Related]
11. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
[TBL] [Abstract][Full Text] [Related]
12. [Co-expression of CFA/I and CS6 of Enterotoxigenic Escherichia coli ( ETEC ) in Shigella flexneri 2a T32 Derivative Strain FWL01].
Zheng JP; Wang LC; Wang P; Luo G; Li SQ; Duan HQ; Huang CF; Zhang ZS
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):1005-10. PubMed ID: 14614538
[TBL] [Abstract][Full Text] [Related]
13. Studies on immunogenicity and protective efficacy of DnaJ of Salmonella Typhi against lethal infection by Salmonella Typhimurium in mice.
Sagi SS; Paliwal P; Bansal A; Mishra C; Khan N; Mustoori SR; Ilavazhagan G; Sawhney RC; Banerjee PK
Vaccine; 2006 Nov; 24(49-50):7135-41. PubMed ID: 16887241
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
Johnson EM; Diena BB; Lior H; Ryan A; Krol P; Baron LS
Infect Immun; 1982 Oct; 38(1):201-5. PubMed ID: 6754614
[TBL] [Abstract][Full Text] [Related]
15. Construction of a bivalent oral vaccine for prevention of typhoid fever and cholera diarrhea.
Ma QJ; Yu XQ; Liu CX; Zhou JG; Xiong LS; Huang CF
Sci China B; 1990 Jan; 33(1):44-9. PubMed ID: 2190570
[TBL] [Abstract][Full Text] [Related]
16. Construction and characterization of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a.
Cryz SJ; Fürer E; Baron LS; Noon KF; Rubin FA; Kopecko DJ
Infect Immun; 1989 Dec; 57(12):3863-8. PubMed ID: 2807550
[TBL] [Abstract][Full Text] [Related]
17. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.
Zhu C; Ruiz-Perez F; Yang Z; Mao Y; Hackethal VL; Greco KM; Choy W; Davis K; Butterton JR; Boedeker EC
Vaccine; 2006 May; 24(18):3821-31. PubMed ID: 16098637
[TBL] [Abstract][Full Text] [Related]
18. Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens.
Gentschev I; Spreng S; Sieber H; Ures J; Mollet F; Collioud A; Pearman J; Griot-Wenk ME; Fensterle J; Rapp UR; Goebel W; Rothen SA; Dietrich G
Chemotherapy; 2007; 53(3):177-80. PubMed ID: 17347563
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
Tacket CO; Pasetti MF; Sztein MB; Livio S; Levine MM
J Infect Dis; 2004 Aug; 190(3):565-70. PubMed ID: 15243933
[TBL] [Abstract][Full Text] [Related]
20. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
Rui X; Xu Y; Wan H; Su G; Huang C
Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
